Allstate (ALL) Stock Analysis 2026: 5.68x PE, ROE 39.5%, and an 80% Forward EPS Jump Ahead of April 29 Earnings

The Allstate Corporation (NYSE: ALL) carries the lowest risk score of any large-cap stock in the Equity Rank screener: 11.0 out of 100, driven by a beta of 0.224, zero Merton default probability, and a distance-to-default of 60 standard deviations. It is among the most stable large businesses in the U.S. market — a property and casualty insurer that survived the worst loss years of the 2020s and is now harvesting the benefits of three years of aggressive rate increases.

At $216.16, Allstate trades at 5.68x trailing earnings and 8.64x forward earnings, with a 70.9 SAVE score, a 37.7% combined margin of safety, and Q1 2026 earnings on April 29, 2026. The forward EPS estimate of $68.53 implies an 80% earnings jump from the already-recovered $38.07 TTM figure.

The Insurance Pricing Cycle: Context for the Numbers

To understand Allstate's 2026 setup, the prior period matters.

From 2020 through 2023, the U.S. property and casualty insurance industry experienced the worst combined-ratio environment in decades:

• Social inflation: Litigation funding and nuclear verdicts drove bodily injury liability claims to record levels.
• Supply chain inflation: Repair costs for vehicles and homes accelerated faster than insurers' premium pricing models had embedded.
• Catastrophe severity: Wildfires in California, hurricanes along the Gulf Coast, and convective storms across the Midwest produced back-to-back elevated loss years.
• Used vehicle appreciation: Total-loss settlements tracked Manheim Index prices, which peaked +54% above pre-COVID levels in 2021–2022.

Allstate's combined ratio (incurred losses + expenses as a percentage of earned premium) exceeded 100% in 2022 and 2023 — meaning the company was paying out more in claims than it collected in premiums before investment income.

The response was decisive: Allstate initiated one of the most aggressive rate increase programs in its history, raising personal auto premiums 20%–30% in most states over 2022–2024. It also withdrew from new homeowner policies in California and reduced its catastrophe-exposed book in Florida.

By Q4 2024, combined ratios had returned below 95%. By TTM 2026, EPS has more than doubled to $38.07, and analysts expect a further 80% jump to $68.53 in FY2026.

Financial Overview

The ROE Story

A 39.5% return on equity is exceptional for any business — and exceptional by insurance-sector standards. The long-run insurance industry ROE median is approximately 12–14%. Allstate's 39.5% reflects the pricing cycle uplift: premium rates that were raised 20–30% are now earning profit on a normalized claims environment.

The PEG ratio of 0.472 — which divides PE by the 5-year EPS growth rate — is below 1.0, indicating the stock screens as cheap relative to its growth trajectory even before the forward earnings acceleration. A PEG below 0.5 is rare at any scale.

Valuation: How the Model Sees $412 When the Stock Trades at $216

Insurance companies require sector-specific valuation methods. The Equity Rank model applies 10 methods to Allstate and synthesizes a consensus:

The P/B Divergence Explained

The model's best-fit method for financials and insurance is P/B — and at $189.66, it sits below the current price. This reflects Allstate trading at 1.82x book value while the insurance sector median P/B is approximately 1.5x–1.6x.

However, P/B-based valuation systematically undervalues high-ROE insurers. The justified P/B formula (ROE / cost of equity) implies that at ROE of 39.5% and a cost of equity of approximately 7–8%, Allstate's justified P/B is approximately 4x–5x book, not 1.5x. On a justified P/B basis, the model computes a fair value near $843 — far above current price.

The model conservatively excludes justified P/B from its consensus. The $412.89 consensus is anchored by P/E (sector median), EV/EBITDA, and Graham Number methods — a reasonable blend.

The honest framing: Allstate's trailing PE of 5.68x is exceptionally cheap by any measure. But the forward PE of 8.64x (based on $68.53 analyst EPS estimate) is the more relevant anchor, and even that implies significant upside versus P/E-based fair values. If forward EPS is achieved, at 12x forward PE the stock's implied value is approximately $822; at 10x, $685; at 8x, $548.

The Forward EPS Thesis: $38 ? $68 in One Year

The single most important data point for Allstate in 2026 is the jump from $38.07 TTM EPS to $68.53 forward EPS — an 80% increase.

Where does this come from?

1. Premium earned catch-up: Rate increases of 20–30% are reflected in full-year earned premium in 2025–2026 (premiums are earned over the policy period; a rate increase approved in Q2 2024 is fully earned by Q2 2025).
2. Normalized catastrophe load: If 2025–2026 avoids a supercatastrophe year (e.g., no Category 4+ Gulf Coast hurricane in a dense metro area), the CAT loss load in earnings normalizes.
3. Investment income expansion: Allstate holds a large fixed income portfolio. With short-duration positioning and reinvestment at 2024–2025 market rates (4–5% vs. prior 2–3%), investment income has expanded without credit risk.
4. Auto frequency normalization: Post-COVID driving behavior and vehicle price normalization reduce per-mile claim frequency relative to 2021–2023 peaks.

The bear case: if 2026 is a record catastrophe year (analogous to 2022 or 2023), the $68.53 forward EPS estimate would be unreachable. Insurance earnings are by definition volatile year-to-year.

SAVE Score Breakdown

Overall SAVE: 70.9 / 100. Risk score: 11.0 / 100 (lower = safer). Combined MoS: 37.7%.

The 11.0 risk score is the standout figure in this profile. It reflects:

• Beta 0.224: Essentially uncorrelated with market daily moves
• Debt/Equity 0.263: Nearly unlevered for an insurance company
• Merton distance-to-default 60: Approximately 60 standard deviations from default — effectively zero credit risk
• 52-week stability: Range of $181.06–$219.48, a 21% band on a $216 stock — modest for a large-cap

Q1 2026 Earnings: April 29 Preview

Allstate reports Q1 2026 earnings on April 29, 2026. Key items to watch:

1. Combined ratio: The single most-watched insurance metric. Q4 2025 reported an auto combined ratio below 90%. Any further improvement (or deterioration) sets the trajectory.
2. Net written premium growth: Rate increases should be largely passed through by now. The question is retention — did customers leave for competitors? Early 2025 data shows retention recovering after initial rate-shock churn.
3. Catastrophe losses: Q1 is typically the lowest CAT quarter (Atlantic hurricane season starts June 1; western wildfire season peaks August–October). Any Q1 CAT loss from winter storms or tornadoes would be disclosed.
4. Investment income: Watch for commentary on portfolio repositioning and realized gains/losses. Allstate has been extending duration cautiously.
5. Full-year guidance: If management raises the full-year combined ratio guidance range or EPS guidance, the stock will react positively. With current consensus at $68.53 FY EPS, a guidance raise implies $70+ and would drive analyst target upgrades.

Allstate's low beta (0.224) suggests muted market-relative reaction to any given earnings print, but insurance-specific surprises (CAT event disclosure, combined ratio miss) can produce outsized stock moves.

Risk Factors

Catastrophe tail risk: The fundamental risk for any P&C insurer. A record Atlantic hurricane season, major California earthquake, or other supercatastrophe event would impair combined ratios materially and pressure EPS. Allstate's 2022 CAT experience ($6.9B in pretax CAT losses) illustrates the range of outcomes.

California exit impact: Allstate has withdrawn from new homeowner policies in California — reducing CAT exposure but also premium volume. Long-term, this is risk-positive; short-term, it suppresses revenue growth.

Forward EPS delivery risk: The $68.53 analyst estimate represents nearly 80% EPS growth in a single year. If claims severity re-accelerates (used vehicle prices, medical cost inflation, legal environment) before earned premium catches up, the estimate may be unachievable.

Regulatory risk: State insurance regulators must approve rate changes. If future rate increases are denied or delayed (particularly in politically sensitive markets), the combined ratio improvement could stall.

Stock near 52-week high: At $216.16, Allstate is within 2% of its 52-week high of $219.48. Technical resistance at all-time-high levels can limit near-term price action even with improving fundamentals.

AI displacement score 67: Insurance underwriting, claims processing, and fraud detection are susceptible to AI-driven efficiency gains — which benefits incumbents — but also to InsurTech disintermediation. The long-term competitive moat should be evaluated.

Analyst Consensus

Analyst consensus target: $240.05 (+11.1% upside from $216.16). The heavy hold distribution reflects that analysts recognize the earnings recovery thesis but see the stock as fairly valued at current price relative to near-term catalysts. A Q1 beat with guidance raise would likely prompt target upgrades from the hold camp.

Positioning Context

Allstate in 2026 is a pure-play on P&C insurance pricing cycle recovery. The company raised rates, fixed its combined ratio, and is now generating record earnings per share. The 5.68x trailing PE and 0.472 PEG say the market has not fully credited the trajectory.

The counterpoint: the 1.82x P/B versus a sector median of ~1.5x means the stock is not deeply cheap on book value — the traditional anchor for insurance valuation. Holders are already paying a ROE premium. Whether the 39.5% ROE is sustainable post-cycle or will mean-revert to the sector's 12–14% norm is the central bear/bull question.

For income-oriented or low-volatility-oriented portfolios, the beta of 0.224 and 2.1% dividend yield make Allstate a distinctive profile — one of the few large-caps in the screener where the primary risk is not market volatility but insurance-specific event risk (which is largely uncorrelated with equity markets).

Tools to Run Your Own Analysis

Use the Equity Rank screener to compare Allstate against other Insurance sector names (Progressive, Travelers, Chubb). The P/E Ratio Calculator translates the $68.53 forward EPS estimate at various multiple assumptions: at 10x PE, fair value = $685; at 12x, $822; at 8x (current sector median), $548. The Book Value Calculator inputs book value per share of $118.54 and current P/B of 1.82x — compare to Progressive's P/B near 7x to contextualize Allstate's still-moderate multiple on book.

This article is for informational and educational purposes only. Equity Rank is not a registered investment adviser. Nothing herein constitutes investment advice or a recommendation to purchase, hold, or sell The Allstate Corporation (ALL) shares or any other security. The 70.9 SAVE score and 37.7% combined margin of safety reflect model outputs based on screener data as of April 19, 2026; they are not guarantees of price appreciation. The model consensus fair value of $412.89 is based primarily on P/E, EV/EBITDA, and Graham Number methods applied at sector median multiples; it differs substantially from the analyst consensus target of $240.05. The forward EPS estimate of $68.53 represents analyst consensus and has not been confirmed by management; insurance company earnings are inherently volatile due to catastrophe event risk, and a significant CAT year could materially impair this estimate. Trailing EPS of $38.07 already reflects significant recovery from loss-year lows; future earnings depend on continued favorable loss ratios and a benign catastrophe environment. Allstate trades within 2% of its 52-week high of $219.48; there is limited near-term technical upside to prior resistance. The April 29, 2026 earnings release may move the stock materially. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Always conduct your own due diligence and consult a qualified financial professional before making investment decisions.